AFRICAN MALARIA NETWORK TRUST
🇹🇿Tanzania
- Country
- 🇹🇿Tanzania
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.amanet-trust.org
Clinical Trials
6
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:5
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (83.3%)Phase 2
1 (16.7%)Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years
Phase 1
- Conditions
- Malaria
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2008-11-25
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 30
- Registration Number
- NCT00703066
- Locations
- 🇬🇦
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
Phase 2
- Conditions
- Malaria
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 378
- Registration Number
- NCT00652275
- Locations
- 🇲🇱
Malaria Research Training Center, Bamako, Mali
Phase Ib Trial of MSP3 LSP in Children in Tanzania
Phase 1
- Conditions
- Malaria
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2007-12-14
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 45
- Registration Number
- NCT00469651
- Locations
- 🇹🇿
Kwashemshi village, Korogwe, Tanga, Tanzania
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
Phase 1
- Conditions
- Malaria
- First Posted Date
- 2007-03-26
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 45
- Registration Number
- NCT00452088
- Locations
- 🇧🇫
Projet de Développement de Vaccins Anti-Paludique- Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Sapone, Burkina Faso
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Phase 1
- Conditions
- Malaria
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 40
- Registration Number
- NCT00431808
- Locations
- 🇲🇱
Malaria Research and Training Center, Bandiagara, Mali
- Prev
- 1
- 2
- Next
News
No news found